References
- Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460–465.
- Bonacci RA, Holtgrave DR. Evaluating the impact of the US National HIV/AIDS strategy, 2010-2015. AIDS Behav. 2016;20(7):1383–1389. doi:https://doi.org/10.1007/s10461-016-1416-8.
- Holtgrave DR, Greenwald R. A SWOT analysis of the updated national HIV/AIDS strategy for the U.S., 2015-2020. AIDS Behav. 2016;20(1):1–6. doi:https://doi.org/10.1007/s10461-015-1193-9.
- Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. doi:https://doi.org/10.1093/cid/ciq243.
- Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012-2013. Clin Infect Dis. 2016;63(7):976–983. doi:https://doi.org/10.1093/cid/ciw418.
- Marks G, Patel U, Stirratt MJ, et al. Single viral load measurements overestimate stable viral suppression among HIV patients in care: clinical and public health implications. J Acquir Immune Defic Syndr. 2016;73(2):205–212. doi:https://doi.org/10.1097/QAI.0000000000001036.
- Genberg BL, Kirk GD, Astemborski J, et al. Durable HIV suppression among people who inject drugs from a community-based cohort study in Baltimore, Maryland, 1997-2017. Am J Epidemiol. 2019;188(12):2086–2096. doi:https://doi.org/10.1093/aje/kwz258.
- Walcott M, Kempf MC, Merlin JS, Turan JM. Structural community factors and sub-optimal engagement in HIV care among low-income women in the Deep South of the USA. Cult Health Sex. 2016;18(6):682–694. doi:https://doi.org/10.1080/13691058.2015.1110255.
- Kalichman S, Kalichman MO, Cherry C. Medication beliefs and structural barriers to treatment adherence among people living with HIV infection. Psychol Health. 2016;31(4):383–395. doi:https://doi.org/10.1080/08870446.2015.1111371.
- Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175–1182. doi:https://doi.org/10.1007/s11606-011-1704-y.
- Grodensky CA, Golin CE, Ochtera RD, Turner BJ. Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. J Stud Alcohol Drugs. 2012;73(6):899–910. doi:https://doi.org/10.15288/jsad.2012.73.899.
- Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183doi:https://doi.org/10.1371/journal.pmed.1002183.
- Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202. doi:https://doi.org/10.1097/QAI.0b013e3181b18b6e.
- Nakimuli-Mpungu E, Bass JK, Alexandre P, et al. Depression, alcohol use and adherence to antiretroviral therapy in Sub-Saharan Africa: a systematic review. AIDS Behav. 2012;16(8):2101–2118. doi:https://doi.org/10.1007/s10461-011-0087-8.
- Jackson JM, Seth P, DiClemente RJ, Lin A. Association of depressive symptoms and substance use with risky sexual behavior and sexually transmitted infections among African American female adolescents seeking sexual health care. Am J Public Health. 2015;105(10):2137–2142. doi:https://doi.org/10.2105/AJPH.2014.302493.
- Johnson SD, Cunningham-Williams RM, Cottler LB. A tripartite of HIV-risk for African American women: the intersection of drug use, violence, and depression. Drug Alcohol Depend. 2003;70(2):169–175. doi:https://doi.org/10.1016/s0376-8716(02)00345-9.
- Mimiaga MJ, August Oddleifson D, Meersman SC, et al. Multilevel barriers to engagement in the HIV care continuum among residents of the state of rhode island living with HIV. AIDS Behav. 2020;24(4):1133–1150. doi:https://doi.org/10.1007/s10461-019-02677-4.
- Bukowski LA, Chandler CJ, Creasy SL, Matthews DD, Friedman MR, Stall RD. Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr. 2018;79(4):413–420. doi:https://doi.org/10.1097/QAI.0000000000001831.
- Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–193. doi:https://doi.org/10.1016/j.drugalcdep.2010.06.014.
- Williams EC, McGinnis KA, Rubinsky AD, et al. Alcohol Use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence? AIDS Behav. 2020. doi:https://doi.org/10.1007/s10461-020-02950-x.
- Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT. Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord. 2015;185:47–59. doi:https://doi.org/10.1016/j.jad.2015.06.024.
- DiPrete BL, Pence BW, Bengtson AM, et al. The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States. AIDS Behav. 2019;23(3):592–601. doi:https://doi.org/10.1007/s10461-018-2282-3.
- Centers for Disease Control and Prevention. HIV/AIDS statistics and surveillance 2015. [Available from: http://www.cdc.gov/hiv/topics/surveillance/basic.htm#hivaidsexposure.
- Boston D. Poverty Rates in Georgia 2008. [Available from: http://poverty.suite101.com/article.cfm/poverty_in_georgia.].
- Van Dam NT, Earleywine M. Validation of the center for epidemiologic studies depression scale-revised (CESD-R): pragmatic depression assessment in the general population. Psychiatry Res. 2011;186(1):128–132. doi:https://doi.org/10.1016/j.psychres.2010.08.018.
- Saunders JB, Aasland OG, Babor TF, DeLaFuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol Consumption-II. Addiction. 1993;88(6):791–804. doi:https://doi.org/10.1111/j.1360-0443.1993.tb02093.x.
- Maisto SA, Conigliaro J, McNeil M, Kraemer K, Kelley ME. An empirical investigation of the factor structure of the AUDIT. Psychol Assess. 2000;12(3):346–353. doi:https://doi.org/10.1037/1040-3590.12.3.346.
- Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior. 2001;5(3):275–281. doi:https://doi.org/10.1023/A:1011396711486.
- Kalichman SC, Amaral C, Swetsze C, et al. Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects. HIV Clin Trials. 2010;11(6):325–331. doi:https://doi.org/10.1310/hct1106-325.
- Kalichman SC, Amaral CM, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308. doi:https://doi.org/10.1310/hct0905-298.
- Conner TS, Barrett LF. Trends in ambulatory self-report: the role of momentary experience in psychosomatic medicine. Psychosom Med. 2012;74(4):327–337. doi:https://doi.org/10.1097/PSY.0b013e3182546f18.
- Heckman BD, Catz SL, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care. 2004;16(2):219–230. doi:https://doi.org/10.1080/09540120410001641066.
- International Advisory Panel on HIVCCO. IAPAC Guidelines for optimizing the HIV care continuum for adults and adolescents. J Int Assoc Provid AIDS Care. 2015;14 Suppl 1:S3–S34.
- Gardner W, Mulvey E, Shaw E. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392–404. doi:https://doi.org/10.1037/0033-2909.118.3.392.
- Glynn TR, Llabre MM, Lee JS, et al. Pathways to health: an examination of HIV-related stigma, life stressors, depression, and substance use. Int J Behav Med. 2019;26(3):286–296. doi:https://doi.org/10.1007/s12529-019-09786-3.
- Sharma R, Yetton P, Crawford J. Estimating the effect of common method variance: the method—method pair technique with an illustration from TAM research. MIS Quarterly. 2009;33(3):473–490. doi:https://doi.org/10.2307/20650305.
- Mellentin AI, Nielsen B, Stenager E, Nielsen AS. The effect of co-morbid depression and anxiety on the course and outcome of alcohol outpatient treatment: A naturalistic prospective cohort study. Nord J Psychiatry. 2015;69(5):331–338. doi:https://doi.org/10.3109/08039488.2014.981857.
- Davidson KM, Blackburn IM. Co-morbid depression and drinking outcome in those with alcohol dependence. Alcohol Alcohol. 1998;33(5):482–487. doi:https://doi.org/10.1093/alcalc/33.5.482.